NF-&kgr;B in Human Disease: Current Inhibitors and Prospects for De Novo Structure Based Design of Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|3|357-374

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.3, 2005-02, pp. : 357-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturally Occurring NF-&kgr;B Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B in Type 1 Diabetes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Signaling in Cartilage: MAPK and NF-&kgr; B Pathways in Chondrocytes and the Use of Inhibitors for Research into Pathogenesis and Therapy of Osteoarthritis

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 305-313

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr; B and Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 359-372

Bentham Science Publishers

Access to resources Recommend Favorite